Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$88.60 – $126.33
96% from low
Exchange
ARCX
ETF
No company description on file.
No one on the platform currently holds PJP.
No tracked institution reports a position in PJP as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-06-22 | $0.2733 | 2026-06-26 |
| 2026-03-23 | $0.3090 | 2026-03-27 |
| 2025-12-22 | $0.2463 | 2025-12-26 |
| 2025-09-22 | $0.2363 | 2025-09-26 |
| 2025-06-23 | $0.2668 | 2025-06-27 |
| 2025-03-24 | $0.2729 | 2025-03-28 |
| 2024-12-23 | $0.2232 | 2024-12-27 |
| 2024-09-23 | $0.2004 | 2024-09-27 |
| 2024-06-24 | $0.2105 | 2024-06-28 |
| 2024-03-18 | $0.1695 | 2024-03-22 |
No one on the platform has traded PJP yet.
| 2023-12-18 | $0.1913 | 2023-12-22 |
| 2023-09-18 | $0.2013 | 2023-09-22 |
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Top 10 Sector ETFs by Momentum Score 📊 (Part 1) Here are the sectors showing the strongest momentum right now: Cybersecurity — 94 | $CIBR Cloud Computing — 91 | $SKYY Banks — 86 | $KBWB Copper Miners — 85 | $COPX Pharmaceuticals — 85 | $PJP Cybersecurity and cloud are standing out, while banks, copper and pharma are also showing solid momentum. I’m watching whether these leaders can maintain strength or if rotation starts showing up elsewhere. The next move usually starts before everyone notices. Stay prepared, not reactive.
View on StockTwits ↗6/8: Abivax raises $920M after full greenshoe; says cash runway extended to end-2029 ahead of late-July FDA pre-NDA meeting for obefazimod $ABVX $XBI $IBB $PJP PickAlpha View: the raise keeps Abivax independent and well funded through key regulatory steps, making the late-July pre-NDA interaction the next driver of near-term positioning. Monitor whether FDA feedback alters NDA timing, labeling...
View on StockTwits ↗3/4: CVS Caremark to re-add Lilly’s Zepbound coverage Oct. 1 and cover new obesity pill Foundayo June 1; GLP-1s from Lilly and Novo become co-preferred on standard commercial formulary covering 25M-30M lives. $LLY $NVO $CVS $XLV $PJP
View on StockTwits ↗What was in the news or going on last time $REGN hit a 52 week low? How much (if any) of a dip do you predict if a potential blockbuster competitor receives potential FDA approval in May 2026 or potentially within 1.5 years? Do you think $REGN may dip below 500 within the next 5 years? Do you think opthalmic bevacizumab might receive FDA approval before or after the next presidential election? Do you think OTLK might take a slice of the wet AMD market and more one day? $PFE $LLY $PJP $MRK
View on StockTwits ↗5 Best Health Sector ETFs to Invest in Long Term. Plus 2 honorable mentions. $BBP - Virtus Biotech ETF $FBT - First Trust NYSE® Arca® Biotechnology Index Fund $XBI - State Street® SPDR® S&P® Biotech ETF $PJP - Invesco Pharmaceuticals ETF $IHE - iShares U.S. Pharmaceuticals ETF Honorable mentions: 6. VHT - Vanguard Health Care ETF 7. IHI - iShares U.S. Medical Devices ETF https://x.com/MicahMcDonald8/status/2043521558837354530?s=20
View on StockTwits ↗Why Did CANF Stock Soar 40% In Pre-Market Today? $CANF $CNCR $PJP $XPH https://stocktwits.com/news/equity/markets/why-did-canf-stock-soar-in-pre-market-today/cZd9miARI5F
View on StockTwits ↗Merck Is Reportedly Splitting Its Pharma Division As Keytruda Patent Nears 2028 Expiry $MRK $PPH $PJP $IYH https://stocktwits.com/news/equity/markets/merck-splitting-pharma-division-keytruda-patent-nears-2028-expiry/cZRt85ZR4yE
View on StockTwits ↗FDA Commissioner Raises Concerns About US Pharma Lagging Behind China In Drug Development $IHE $PJP $XPH https://stocktwits.com/news/equity/markets/fda-commissioner-raises-concerns-about-us-pharma-lagging-behind-china-in-drug-development/cZRKIGlR4wT
View on StockTwits ↗$PJP Current Stock Price: $105.14 Contracts to trade: $100 PJP Feb 20 2026 Call Entry: $5.00 Exit: $8.37 ROI: 67% Hold ~25 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
View on StockTwits ↗Why Did OCUL Stock Jump 13% In Pre-Market Today? $OCUL $VTI $PJP $URTY $SNY https://stocktwits.com/news/equity/markets/why-did-ocul-stock-jump-13-in-pre-market-today/cmU1KclR47Y
View on StockTwits ↗$CORT 6 analysts gave average target of $127 for 250% upside from current $35 level. That said, after today's news, I'm sure analysts will update their targets in coming days and this will come down, but I'm still thinking it'll be over 100% upside potential. $IHE $XPH $PJP $PPH
View on StockTwits ↗$CORT Hitting 52 week low in pre-market. Like to start accumulating near $40 if it can get there. $IHE $XPH $PJP $PPH
View on StockTwits ↗$CORT Tanking -35% in premarket on FDA CRL. Price looks attractive but let me first do some more detail study before entering. $IHE $XPH $PJP $PPH
View on StockTwits ↗#Pharma's $370 Billion #Bet On #America: The #ETF Plays For 2026 $IHE $PJP $PPH Also $ABT $GSK https://talkmarkets.com/content/us-markets/pharmas-370-billion-bet-on-america-the-etf-plays-for-2026?post=546051&userid=123969
View on StockTwits ↗US-UK Near Landmark Zero-Tariffs Pharma Deal, Announcement Expected Soon: Report $AZN $PPH $IHE $PJP https://stocktwits.com/news/equity/markets/us-uk-agree-zero-tariffs-deal-pharmaceuticals/cLI7O6VREiQ
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.